SCHEMBL8734102

SCHEMBL8734102

C[Si](C)(C)c1ccc(/C=C/c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RELA Q04206 3/20 0.50
MAOB P27338 2/20 0.50
TRPA1 O75762 1/20 0.50
NFE2L2 Q16236 1/20 0.50
CYP19A1 P11511 1/20 0.50
MAOA P21397 1/20 0.50
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
CHAT P28329 2/20 0.46
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 3/20 0.45
HPGD P15428 3/20 0.45
CYP11B1 P15538 1/20 0.45
CYP11B2 P19099 1/20 0.45
TUBB1 Q9H4B7 1/20 0.44
GRM5 P41594 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
GRM4 Q14833 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8734104 1.00 RELA (0.50) RELAMAOBTRPA1NFE2L2CYP19A1
SCHEMBL29794003 1.00 RELA (0.50) RELAMAOBTRPA1NFE2L2CYP19A1
SCHEMBL8733107 0.90 NR1H2 (0.39) RELAMAOBTRPA1NFE2L2CYP19A1
SCHEMBL8733104 0.90 NR1H2 (0.39) RELAMAOBTRPA1NFE2L2CYP19A1
SCHEMBL10031943 0.86 ESR1 (0.52) RELAMAOBTRPA1NFE2L2CYP19A1
SCHEMBL8733095 0.83 NFE2L2 (0.43) RELAMAOBNFE2L2CYP19A1MAOA
SCHEMBL8733093 0.83 NFE2L2 (0.43) RELAMAOBNFE2L2CYP19A1MAOA
SCHEMBL6123486 0.81 RELA (0.47) RELAMAOBTRPA1NFE2L2CYP19A1
SCHEMBL8733085 0.80 NFE2L2 (0.50) RELAMAOBNFE2L2CYP19A1MAOA
SCHEMBL8733083 0.80 NFE2L2 (0.50) RELAMAOBNFE2L2CYP19A1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234900-A1 METHODS OF ARENE ALKENYLATION UNIVERSITY OF VIRGINIA PATENT FOUNDATION 2023-07-27 US disclosed
EP-0722959-B1 Highly oxygen-permeable heat-resistant material MENICON CO LTD (JP) 1998-04-08 EP disclosed
US-5587445-A Highly oxygen-permeable heat-resistant material MENICON CO., LTD. (JP) 1996-12-24 US disclosed
EP-0722959-A2 Highly oxygen-permeable heat-resistant material Menicon Co., Ltd. (JP) 1996-07-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234900-A1 METHODS OF ARENE ALKENYLATION CYBB, CBR3, AHR RELA 732/4885MAOB 157/4885TRPA1 1407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.